The Bioplasm NLS belongs to a class of devices that can be used to assess your risk of diseases at the pre-clincal stage. It has also therapeutic value in treatment of these pre-clinical problems, to prevent their degeneration into disease stage. In other words, it is very useful both for sub-health state screening and therapy.
This is an example of how to use the device....A recent piece of research shows:
White Matter Damage in Brain May Help Spot Early Alzheimer's
Damage to the brain's white matter may be an early sign of certain types of Alzheimer's disease, according to a new study.
"Alzheimer's is a gray matter disease. However, white matter damage has a central role in how the disease strikes and progresses," study co-author Dr. Federica Agosta, from the Neuroimaging Research Unit at the San Raffaele Scientific Institute in Milan, Italy, said in a news release from the Radiological Society of North America.
The findings support the theory that Alzheimer's disease may travel along white matter fibers from one area of the brain to another, according to Agosta.
"In early onset AD [Alzheimer's disease] and atypical AD forms, white matter degeneration may be an early marker that precedes gray matter atrophy," she said. "Because there is not much structural damage in the early stages of focal Alzheimer's disease, there is a risk that patients may be misdiagnosed.